Tuesday, Jan 25, 2022 - 00:42:55
38 results - (0.000 seconds)

Baltimore plant:

latest news at page 1:
1
    This content was republished with permission from WTOP’s news partners at Maryland Matters. Sign up for Maryland Matters’ free email subscription today. The state of Maryland filed a lawsuit against Baltimore on Friday over untreated sewage discharge into the Chesapeake Bay by two Baltimore wastewater treatment plants. Last summer, Blue Water Baltimore, an environmental watchdog group, found high bacteria levels in the city’s harbor near the Patapsco Wastewater Treatment Plant, which is operated by the city, and reported it to the Maryland Department of the Environment. MDE found similar sewage outflow violations during an inspection at the Back River Wastewater Treatment, which is also operated by the city. The lawsuit, filed by Maryland Attorney General Brian E. Frosh (D) on behalf of the Maryland Department of the Environment in Baltimore City Circuit Court, includes fines of up to $10,000 every day the two largest wastewater treatment plants in the state continue to discharge more than their permitted amount. The lawsuit lists 10 permit violations for the Back River plant and nine permit violations for the Patapsco plant. MDE inspected both of the...
    BALTIMORE (WJZ) — Surveillance video shared by a local business owner shows the moments an explosion occurred Thursday at a Baltimore coal plant, sending flames and smoke shooting into the air. The video clip was provided to WJZ by Howard Rosenberg, the owner of Beltsville Auto Recyclers, which is located a little bit more than a mile away from the CSX Curtis Bay Coal Terminal in South Baltimore. READ MORE: Man, 23, Grazed In Head By Gunfire In West Baltimore, Police SayAbout five seconds into the clip, the blast can be seen in the background, trailed by plumes of smoke. From the auto salvage lot, the smoke can be seen expanding as it rises into the air above the plant. READ MORE: Mayor Scott To Host New Year's Day Vigil Honoring Lives Lost In 2021Authorities said coal was being moved on a conveyor belt at the CSX plant shortly before 11:30 a.m. Thursday when a coal dust explosion happened. Fortunately, no one was hurt, but the blast damaged nearby homes and businesses and its shockwaves were felt across the city....
    BALTIMORE (WJZ) — A fire was reported on Johns Hopkins University’s Homewood campus in north Baltimore Friday morning, according to the Baltimore firefighters union. Units responded to the scene around 11:30 a.m. at the 3400 block of N. Charles Street, where smoke was showing from the air handling unit on the roof of a power plant on campus. READ MORE: COVID-19 In Maryland: 909 New Cases, 10 New Deaths ReportedFirefighters said students and staff should follow evacuation orders from university security. READ MORE: Did Miami Unlock The Key To Beating The Ravens?The extent and scope of the fire is unclear at this time. No injuries have been reported. This is a developing story and will be updated. ????WORKING BUILDING FIRE????Homewood Power Plant3400 N Charles St 21218#JohnsHopkinsHomewood @JohnsHopkins@odetteramos#BMORESBravest arrived with smoke showing from the air handling unit on the roof. Affected students & staff should follow evacuation orders from JHU Security. pic.twitter.com/407wXMU9Nd — Baltimore Firefighters IAFF Local 734 (@BCFDL734) November 12, 2021 MORE NEWS: An Unhappy Homecoming This Time For Ravens QB Lamar Jackson 
    BALTIMORE (WJZ) — Volunteers are helping the Baltimore Tree Trust plant 100 trees in an empty space in the Cherry Hill neighborhood. “The Baltimore Tree Trust is really focused on increasing the tree canopy in Baltimore city,” MedStar Harbor Hospital Green Team member Joan Plisko said. READ MORE: Howard County Invites Nonprofits To Apply For $500K In Grant Funding For 'Innovative' IdeasThe trees are being planted near MedStar Harbor Hospital in an area that will be called MedStar Harbor Park West. Eventually, walkways and benches will be added too. “We really focus on highlighting neighborhoods that really aren’t accessing those resources or have access to those resources,” Baltimore Tree Trust Communications and Outreach Manager Ryan Alston said. READ MORE: Fall Foliage Report: Central Maryland Halfway To Peak ColorsThis project stemmed from another project at the hospital where trees were planted to help control stormwater runoff. The money to plant the trees came from a grant from the Arbor Day Foundation. The Foundation and UPS volunteered to help plant the trees. “Trees are good for the environment,” Plisko said. “They’re good...
    SPARROWS POINT, Md. (WJZ) — Steel production is one step closer to returning to Sparrows Point in Baltimore County. A long-term lease agreement between US Wind and Tradepoint Atlantic, which owns the former Bethlehem Steel property, was signed Tuesday. READ MORE: Southwest Baltimore Man Sentenced For Distributing Child Pornography While On Probation For Sex Offense US Wind is in the process of building Maryland’s first major offshore wind farm off the coast of Ocean City, known as the MarWin project. Currently, materials for the 22 wind turbines are made in Europe. Pending approvals and permitting, turbines for future projects, including US Wind’s Momentum Wind project off the Maryland coast, will be made at Sparrows Point, representing the return of steel jobs on the southeast Baltimore County site. “It’s very emotional,” said Jim Strong, a representative from United Steelworkers. “To bring the steelworkers back to Sparrows Point is huge. We’ve always viewed this area as sacred ground.” READ MORE: Officer Dead, Suspect Killed In Violence Outside Pentagon Once home to the world’s largest steel plant, the last steel mill closed...
    The Food and Drug Administration has cleared the manufacturer responsible for contaminating millions of vials of COVID-19 vaccines to resume production at its Baltimore plant. “We are proud to be resuming production of bulk COVID-19 vaccine batches following additional reviews and collaboration with FDA and our manufacturing partners,” Emergent BioSolutions Robert Kramer said in a statement Wednesday, according to The Wall Street Journal. The plant was responsible for contaminating 75 million doses of the Johnson & Johnson and AstraZeneca vaccines at its Baltimore facility, with 30 million J&J doses produced by the plant waiting for FDA clearance. A source told the Journal that the plant could end up making 120 million doses a month of the J&J vaccine, but those vials may not be shipped until the fall. The U.S. has seen a lack of interest in the one-dose treatment, which has been marred by different problems, resulting in it exporting the vials to other countries in need.
    Lawmakers are expanding their probe of the troubled Emergent BioSolutions vaccine plant, and are now focusing attention on the manufacturing contracts with AstraZeneca and Johnson & Johnson. Democrats on two House panels in letters dated Tuesday asked the CEOs of AstraZeneca and Johnson & Johnson to produce all communications related to efforts to supervise manufacturing, quality, or compliance of their vaccines at Emergent's plant in Baltimore.  The lawmakers also asked the companies to produce all records related to their decisions to hire Emergent as a subcontractor, as well as the specific numbers of doses that have either been destroyed, delayed, or shipped. The company is facing scrutiny from Congress after it was awarded a $628 million contract last year to establish the primary U.S. facility for manufacturing vaccines developed by Johnson & Johnson and AstraZeneca. The congressional investigation has already shown that the company received numerous warnings about its potential manufacturing problems but did not take action.  The plant has been forced to destroy the equivalent of tens of millions of doses of Johnson & Johnson’s coronavirus vaccine because of...
    BALTIMORE (WJZ) — The U.S. Food And Drug Administration announced Tuesday that they are authorizing an additional batch of the Johnson & Johnson coronavirus vaccine produced at Emergent BioSolutions. “To date a total of three batches of Janssen drug substance that were manufactured at the Emergent facility have been authorized, the FDA said in a statement. “The FDA conducted a thorough review of facility records and the results of quality testing performed by the manufacturer.” READ MORE: FDA Orders J&J Vaccines Made At Baltimore Emergent Plant To Be Tossed Based of their review, they determined that the batches are suitable for use. In statement, Emergent said, “With respect to the news from last night, we did issue a comment: We welcome the approval of an additional batch of J&J vaccine made at Emergent. We remain committed to addressing the FDA’s observations in order to resume production as soon as possible and look forward to continuing our work to end this pandemic.” On Friday, the FDA announced the release of 10 million doses of Johnson & Johnson’s COVID-19 vaccine from Emergent...
    The Food and Drug Administration on Tuesday announced that it had authorized an additional batch of Johnson & Johnson COVID-19 vaccine that had been produced from a troubled Baltimore facility. The news, posted in a press release on FDA’s website, comes days after the agency had authorized two batches from the Emergent BioSolutions plant but found "several other batches" not suitable for use.  A New York Times report citing people familiar with the situation said the company was directed to toss about 60 million doses that had been produced at the facility. Tuesday’s update again noted that the regulatory agency is "not yet ready to include the Emergent BioSolutions plant in the Janssen EUA as an authorized manufacturing facility." The FDA said it "continues to work through issues there" with both Johnson & Johnson and Emergent BioSolutions.  The company has been told previously to discard doses from the plant, which has been repeatedly cited for problems pertaining to poorly trained employees, cracked vials and mold issues, according to the Associated Press.  CDC PANEL TO DISCUSS COVID-19 VACCINATION, RARE HEART ISSUES...
    (CNN)The US Food and Drug Administration announced Friday it was authorizing for use two batches of Johnson & Johnson Covid-19 vaccines -- roughly 10 million doses -- that were produced at the troubled Emergent BioSolutions facility in Baltimore. This is a significant development, given not a single usable dose of the Johnson & Johnson Covid-19 vaccine from that facility had been approved yet. "Before making this decision, the FDA conducted a thorough review of facility records and the results of quality testing performed by the manufacturer. Based on this review and considering the current COVID-19 public health emergency, the FDA concluded these batches are suitable for use," the FDA said in a statement. Kathy Wengel, executive vice president and chief global supply chain officer for Johnson & Johnson, hailed the progress Friday. "Today's decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, and we appreciate the close collaboration with the FDA and global health authorities," Wengel said in a statement. "The Company continues to substantially expand its global vaccine manufacturing network...
    BALTIMORE (WJZ) — The Food and Drug Administration is forcing Johnson & Johnson to throw out millions of vaccine doses made at a plant here in Baltimore. The FDA, for months, had been reviewing and testing the doses manufactured at the Emergent Biosolutions facility here in Baltimore. READ MORE: Robertas House Holds Grand Opening For Family Grief Support Center The FDA said “several batches” of the J&J vaccine made here in Baltimore need to be tossed. The New York Times is reporting that number totals 60 million doses. “It’s obviously very tragic that now an additional 60 million doses will have to be discarded because of the problems at this plant at a time there’s a huge global shortage of vaccines,” said Dr. Bill Moss, professor at Johns Hopkins University Bloomberg School of Public Health and executive director of the International Vaccine Access Center. The Emergent plant has been closed for two months. An FDA report released in April showed a number of issues at the plant, including “the design of the building,” “improper medical waste handling,” “peeling paint,” “black...
    Federal regulators have instructed Johnson & Johnson to discard roughly 60 million single-shot COVID-19 vaccines due to possible contamination following a manufacturing mishap at the Baltimore-based Emergent BioSolutions, an error that shut down the plant two months ago. The Food and Drug Administration told the company to throw out the shots, and it has not yet decided whether the plant can reopen, according to the New York Times. Federal regulators closed the plant two months ago amid reports that factory workers mistakenly contaminated 15 million J&J shots with the key ingredient for the AstraZeneca vaccine, which was also in production at that plant, even though it has not yet passed regulatory muster in the United States. JOHNSON & JOHNSON VACCINE SHIPMENTS TO BE DELAYED AFTER PRODUCTION MIX-UP RUINS 15M DOSES The mix-up caused federal officials to strip the plant of its responsibility to produce the AstraZeneca vaccine and handed over production authority to J&J. The J&J vaccine was authorized for public use by the FDA in February. It is the first single-dose COVID-19 vaccine to...
    The U.S. Food and Drug Administration (FDA) ordered Johnson & Johnson to discard 60 million COVID-19 vaccine doses on Friday. The shots were made at a plant in Baltimore that had several health violations and ruined million of doses of J&J vaccine during an ingredient mix-up. People familiar with the situation told The New York Times that the FDA said the shots have to be thrown away due to potential contamination. The contract J&J signed with the U.S. government last year priced each dose at roughly $10, meaning $600 million worth of doses are being tossed out - but it's not believed federal officials with pay the company for these jab. Earlier in the day, the FDA allowed 10 million doses to be distributed in the U.S. and to other countries, but with a caveat that there is no guarantee the J&J shots were made under good manufacturing practices. It has not been decided yet whether not the plant, run by Emergent BioSolutions, will be allowed to reopen after closing two months ago.    Officials say there is no cause for concern...
    The U.S. Food and Drug Administration (FDA) ordered Johnson & Johnson to discard 60 million COVID-10 vaccine doses on Friday. The shots were made at a plant in Baltimore that had several violations and ruined 15 million doses of the vaccine during an ingredient mix-up. People familiar with the situation told The New York Times that FDA said the shots have to be thrown away due to potential contamination. Earlier in the day, the health agency allowed 10 million doses to be distributed in the U.S. to other countries, but with a caveat that there is no guarantee the J&J shots wee made under good manufacturing practices. It has not been decided yet whether not the plant, run by Emergent BioSolutions, will be allowed to reopen after closing two months ago.   Officials say there is no cause for concern because all J&J doses administered in the U.S. so far were manufactured at the firm's Janssen plant in the Netherlands, not at the Baltimore plant.  The FDA has ordered 60 million doses of Johnson & Johnson's coronavirus vaccine to be...
    BALTIMORE (WJZ) — Two new restaurants will open in the Inner Harbor in Baltimore on July 1. Matthew Kenney Cuisine will open Double Zero, the fourth location of its pizzeria, and Liora, which the company said is a unique restaurant serving locally sourced fare in a seasonally crafted menu. The locations will be in the 400 block of Light Street. READ MORE: Child Tax Credit: How Much Will Your Monthly Check Be? Courtesy: Matthew Kenney Cuisine Liora also will feature a wine list of organic and biodynamic varietals, a menu that pays homage to local cuisine, including crab cakes and barbecue, according to a statement from the “plant-based lifestyle brand celebrity chef Matthew Kenney founded. READ MORE: Over 15K Unemployment Claims Filed In Maryland Last Week Double Zero offers what MKC describes as plant-based pies and a healthy perspective to pizza. Options include truffle, eggplant parmesan, bianca and spicy pepperoni pizzas. Besides the crab cakes at Liora, the location also plans to serve cacio e pepe made of kelp noodles, as well as a plant burger and barbecue beets. MORE...
    Workers at a Baltimore plant producing Johnson & Johnson's COVID-19 vaccines failed to shower or change clothes regularly, according to a report released by the US House Oversight Committee on Wednesday.  On March 31, J&J was forced to discard 15 million doses of their vaccine after they were contaminated by staff at the Emergent BioSolutions plant. The disaster prompted a probe by US lawmakers, with Wednesday's report detailing a myriad of problems inside the facility.   J&J locked arms with Emergent in April 2020, enlisting the lesser-known company to manufacture the vaccine that they were developing with federal funding from Operation Warp Speed. The US government reportedly awarded Emergent with a $628 million contract to help produce the vaccines.   However, Emergent's Baltimore facility wasn't scaled for making millions of doses of a potential COVID-19 vaccine, according to an FDA inspection which was conducted last year.  The FDA records - released as part of Wednesday's report - described the plant as a contract testing laboratory that 'did not manufacture products for distribution.'  Workers at a Baltimore plant producing Johnson & Johnson's COVID-19 vaccines failed...
    BALTIMORE (WJZ) — A local plant expert now has his own line of plants and accessories at Target. Hilton Carter is launching his collection Friday. READ MORE: Would You Eat A Cicada? They Apparently Taste Like Shrimp! The limited-time collection of faux and live plants and accessories is in select stores and online. The items will be available until supplies last. READ MORE: Fire Reported At Windsor Mill Home WJZ spoke to Hilton on Coffee With about his third book, “Wild Creations.” You can watch that interview below. MORE NEWS: Stimulus Check Update: Will You Get A Fourth Relief Payment?
    BALTIMORE (WJZ) — Emergent BioSolutions said it hopes to respond to federal regulators within days on how to resolve the problems at its East Baltimore plant. It’s the same facility that ruined 15 million doses of the Johnson & Johnson coronavirus vaccine. READ MORE: Service Restored After Water Main Breaks In Front Of Perry Hall Home The FDA halted production at Emergent, and earlier this month released a report on its concerns over cross-contamination and sanitation inside the facility. READ MORE: Howard County, Safeway Partner To Vaccinate More Of Its Residents Emergent President and CEO Robert G. Kramer Sr. said the company hopes to meet or exceed FDA standards moving forward. He said the company has been “steadfast in its commitment to quality,” since its founding and took full responsibility for the incident. MORE NEWS: Reward Offered For Man Sought In Armed Robbery at Joppa Marijuana Dispensary Kramer credited the mistake on the feat of the endeavor itself, and the company’s “bold” moves of preparing the Bayview plant to be able to quickly produce millions of Johnson & Johnson doses...
    The CEO of the drugmaker that ruined 15 million doses of Johnson & Johnson's COVID-19 vaccine sold off more than $10 million worth of his stock in his company before the price tumbled.  Emergent BioSolutions CEO Robert Kramer sold off the stock in his company in January and February, the Washington Post reports.  The 64-year-old's $10 million sell off came prior to his company's stock plunging on February 19 about 50 percent. Emergent's stock has fallen from $125 a share to $62 a share since mid-February.  His stock would now be worth about $5.5 million.  Emergent, which is a government contractor, is the company that owns and runs the Baltimore plant that was making Johnson & Johnson's COVID-19 vaccine. Quality problems at the company resulted in Johnson & Johnson having to discard 15 million doses of its vaccine on March 31.  Emergent BioSolutions CEO Robert Kramer, 64, sold off the $10 million of stock in his company in January and February, the Washington Post reports According to securities filings, it was Kramer's first substantive sale of his Emergent stock since back...
    The New York Times Vaccines Made at Troubled Baltimore Plant Were Shipped to Canada and Mexico WASHINGTON — The Biden administration said Friday that it did not know that a Baltimore factory had discarded millions of possibly contaminated doses of AstraZeneca’s coronavirus vaccine when President Joe Biden last month released the company to ship vaccines manufactured there to Mexico and Canada. Canadian and Mexican officials said Friday that they had assurances from AstraZeneca that the millions of doses they received were safe. Some of the doses have been distributed to the public in both countries, the officials said. Biden administration officials said they had not vouched for the quality of the AstraZeneca vaccine doses made at the Baltimore plant, leaving the decision on whether to use them to the company and the Canadians and Mexicans themselves. Sign up for The Morning newsletter from the New York Times The administration, however, did inform the two countries of another episode of possible contamination, involving a similar vaccine developed by Johnson & Johnson, that occurred more recently at the same Baltimore plant. Vaccine...
    The New York Times Vaccines Made at Troubled Baltimore Plant Were Shipped to Canada and Mexico WASHINGTON — The Biden administration said Friday that it did not know that a Baltimore factory had discarded millions of possibly contaminated doses of AstraZeneca’s coronavirus vaccine when President Joe Biden last month released the company to ship vaccines manufactured there to Mexico and Canada. Canadian and Mexican officials said Friday that they had assurances from AstraZeneca that the millions of doses they received were safe. Some of the doses have been distributed to the public in both countries, the officials said. Biden administration officials said they had not vouched for the quality of the AstraZeneca vaccine doses made at the Baltimore plant, leaving the decision on whether to use them to the company and the Canadians and Mexicans themselves. Sign up for The Morning newsletter from the New York Times The administration, however, did inform the two countries of another episode of possible contamination, involving a similar vaccine developed by Johnson & Johnson, that occurred more recently at the same Baltimore plant. Vaccine...
    BALTIMORE (WJZ) — Baltimore City Fire officials are investigating the cause of a three-alarm fire at the Domino Sugar building on Tuesday afternoon. Fire crews responded around 3 p.m. after reports of heavy smoke in the area. READ MORE: No Injuries So Far In 2-Alarm Fire On Reisterstown Road In Baltimore, Fire Officials Say “We had people calling in to say they could see smoke from miles and miles away,” Blair Adams, of the Baltimore City Fire Department, said. When crews arrived on the scene, they made their way to a storage shed at the building. “It’s insane,” Pierre Aguilar, a Dominio Sugar factory worker, said. “It’s crazy. In the shed, it’s all raw sugar. Whatever comes off the ship goes into that shed.” LATEST on #DominoSugar factory fire: BCFD says shortly after 3 p.m, crews arrived on scene after reports of heavy smoke in the area. When crews arrived on scene, there was a heavy fire showing from the center of the silo (roughly around or inside) which partially collapsed. — Amy Kawata TV (@AmyKawata) April 20, 2021 ...
    The Food and Drug Administration reported significant sanitation issues at the Emergent BioSolutions manufacturing plant where 15 million doses of the Johnson & Johnson coronavirus vaccine were ruined. “Emergent is committed to working with the FDA and Johnson & Johnson to quickly resolve the issues identified,” the Baltimore plant said on Wednesday. “While we are never satisfied to see shortcomings in our manufacturing facilities or process, they are correctable and we will take swift action to remedy them." The FDA’s inspection of the Emergent BioSolutions facility revealed that the plant “is not maintained in a clean and sanitary condition.” The 13-page report described “unsanitary” conditions, such as poor decontamination procedures and unsafe disposal of manufacturing waste that the agency said has the potential to infect other parts of the manufacturing warehouse. The FDA also found damaged floors, peeling paint, and wall damage that impede the staff’s ability to disinfect the plant where the vaccines are made. JOHNSON & JOHNSON PAUSE MAKES IT HARDER TO VACCINATE RELUCTANT, HARD-TO-REACH PATIENTS “There is no assurance that other...
    A detail of Janssen Johnson & Johnson COVID-19 vaccine that is not currently being given out because it has been put on hold.Allen J. Schaben | Los Angeles Times | Getty Images The Food and Drug Administration said Wednesday a Baltimore plant that ruined millions of Johnson & Johnson Covid-19 vaccine doses was unsanitary and unsuitable to manufacture the shots. The FDA asked Emergent BioSolutions, which runs the plant, to temporarily stop producing materials for Covid-19 vaccines earlier this month as the U.S. agency initiated an inspection. The Biden administration put J&J in charge of the Baltimore plant after U.S. officials learned that Emergent, a contract manufacturer that had been making vaccines for J&J and AstraZeneca, mixed up ingredients for the two shots. Officials also stopped production of the AstraZeneca vaccine. This is a developing story. Please check back for updates.
    The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021.Saul Loeb | AFP | Getty Images The Food and Drug Administration has asked Emergent BioSolutions to temporarily stop producing materials for Covid-19 vaccines while U.S. regulators investigate its plant in Baltimore responsible for ruining millions of Johnson & Johnson shots, Emergent said in a regulatory filing Monday. This is a developing story. Please check back for updates.
    Emergent BioSolutions, the manufacturer at the center of the Johnson & Johnson coronavirus vaccine bungle, gave its chief executive officer a 51 percent compensation bump in 2020 — bringing his total remuneration to a whopping $5.6 million. On top of a lucrative $893,000 salary, CEO Robert Kramer received a $1.2 million bonus and $3.5 million in stock awards and options, according to the company’s filing with the Securities & Exchange Commission late Friday. Emergent’s response to the COVID-19 pandemic last year contributed Kramer’s juiced-up compensation package, the company said, citing the expansion of its contract manufacturing business. The Maryland-based biopharmaceutical company boasted a 41 percent increase in revenue in 2020, after it inked vaccine manufacturing deals with J&J and AstraZeneca at its Baltimore plant. Its success was also largely fueled by a massive $628 million federal contract to upgrade and reserve capacity, in order to fulfill government vaccine orders and fight the pandemic. The Emergent BioSolutions plant in Baltimore is not currently authorized to supply Johnson & Johnson vaccines to Americans.SAUL LOEB/AFP via Getty Images But problems at...
    More On: johnson & johnson Man in hospital with COVID after being fully vaccinated Blood clots in Johnson & Johnson COVID vaccine recipients under investigation Woman gets COVID 3 weeks after Johnson & Johnson vaccine US deliveries of Johnson & Johnson vaccine to plummet 80 percent next week Emergent BioSolutions, the manufacturer at the center of the Johnson & Johnson coronavirus vaccine bungle, gave its chief executive officer a 51 percent compensation bump in 2020 — bringing his total remuneration to a whopping $5.6 million. On top of a lucrative $893,000 salary, CEO Robert Kramer received a $1.2 million bonus and $3.5 million in stock awards and options, according to the company’s filing with the Securities & Exchange Commission late Friday. Emergent’s response to the COVID-19 pandemic last year contributed Kramer’s juiced-up compensation package, the company said, citing the expansion of its contract manufacturing business. The Maryland-based biopharmaceutical company boasted a 41 percent increase in revenue in 2020, after it inked vaccine manufacturing deals with J&J and AstraZeneca at its Baltimore plant. Its success was also largely...
    Vials labelled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021.Dado Ruvic | Reuters Johnson & Johnson is scaling back shipments of its single-dose Covid-19 vaccine by 86% next week as it grapples with manufacturing issues at a major plant in Baltimore. The government has allocated only 700,000 J&J shots to states next week, down from 4.9 million the week prior, according to data from the Centers for Disease Control and Prevention. J&J is awaiting regulatory clearance for a Baltimore facility, which is run by Emergent BioSolutions Inc, and is working with the U.S. Food and Drug Administration to secure authorization. Workers at the Baltimore plant several weeks ago mixed up ingredients for the J&J and AstraZeneca vaccines, which led to roughly 15 million ruined J&J doses. The Biden administration has put J&J in charge of vaccine manufacturing at the plant and stopped production of the AstraZeneca vaccine there. Once it receives authorization, J&J could deliver up to eight million doses each week, White House Covid-19 coordinator...
    The Baltimore plant that discarded 15 million doses of Johnson & Johnson’s COVID-19 vaccine threw away up to 15 million doses last year and may have to scrap up to 130 million more due to shoddy factory conditions, it has been reported. Emergent BioSolutions announced last week that it was forced to throw out 15 million doses of the J&J vaccine due to fears that the vaccine was contaminated with elements of the AstraZeneca vaccine. The loss of the 15 million doses came just months after the same Baltimore plant had to discard between 10 and 15 million doses of the AstraZeneca vaccine due to suspected contamination, according to The New York Times. The mishaps took place after Emergent received a $628million contract from the federal government to improve the plant and prepare to manufacture a high volume of vaccine.  It then struck deals with J&J and AstraZeneca for a combined $875million. In total, Emergent received $1.5billion to churn out hundreds of millions of doses of COVID-19 vaccine - though so far none of have been administered, according to the...
    BALTIMORE (WJZ/CBS NEWS) — Maryland Governor Larry Hogan said he learned yesterday along with the public about the mix-up at Baltimore’s Emergent BioSolutions plant weeks ago that reportedly ruined almost 15 million doses of the Johnson & Johnson vaccine. “It was not mentioned by The White House on our Tuesday call. We at this point don’t know the exact impact that it’s going to have although we’ve been lead to believe by our federal partners that it’s not going to directly impact our allocations at least for the foreseeable future, and we’re hoping that is the case,” Hogan told reporters. “I don’t think it gives Baltimore a bad name. I mean obviously, there was some major screw-up at this plant with human error of some type.” READ MORE: Congressman Dutch Ruppersberger Demands Action On Postal Delays The facility has yet to be approved by the Food and Drug Administration, and none of the vaccines manufactured here have been given to the general public. “It was human error. The FDA is investigating this,” said Dr. Anthony Fauci, a senior adviser to the...
    (CNN)Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its coronavirus vaccine under contract.The New York Times reported Wednesday. that workers at Emergent, the Baltimore plant that has been making Johnson & Johnson's Covid-19 vaccine, accidentally mixed up some of the ingredients, ruining as many as 15 million potential doses of vaccine and delaying US Food and Drug Administration authorization of the plant. Emergent is also making the AstraZeneca vaccine which has yet to be authorized for use in this country. CDC director tells Americans they are at a critical point in the Covid-19 pandemicJohnson & Johnson said in a statement to CNN Wednesday that the quality control process at the plant identified "one batch" of drug substance that did not meet quality standards. The batch in question was part of a test run and quality check. The site is not yet authorized by the FDA to make the drug substance used in the vaccine. "This batch was never advanced to the filling and finishing stages of our manufacturing process," the...
    Workers at a Baltimore plant responsible for producing two separate coronavirus vaccines mistakenly mixed up their respective ingredients, ruining approximately 15 million doses of Johnson & Johnson’s vaccine and pausing all production at the plant, the company confirmed Wednesday. The facility, run by Emergent BioSolutions, had partnered with both Johnson & Johnson and AstraZeneca to produce vaccines. Federal officials said that the mistake was a result of human error, according to The New York Times, which first reported the mix up that reportedly occurred several weeks ago. A quality control review “identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our COVID-19 vaccine,” Johnson & Johnson said in a statement. “This batch was never advanced to the filling and finishing stages of our manufacturing process.” Johnson & Johnson’s vaccine was the third to be approved in the United States, but is the only-one dose vaccine available. The doses currently being delivered and administered were not affected by the error, since they were manufactured in...
    Stephen Zenner/Getty Images A stunning new report in the New York Times says that future shipments of the Johnson & Johnson vaccine have been halted for the time being due to human error that ruined 15 million doses of the vaccine. To be clear, the Times report says this “does not affect Johnson & Johnson doses that are currently being delivered and used nationwide.” “All those doses were produced in the Netherlands, where operations have been fully approved by federal regulators,” it adds. But future shipments of the one-dose shot — the third safe and effective Covid-19 vaccine approved by the FDA — are apparently being halted for the time being over a serious error at a Baltimore plant: Workers at a Baltimore plant manufacturing two coronavirus vaccines accidentally conflated the vaccines’ ingredients several weeks ago, ruining about 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay authorization of the plant’s production lines… [A]ll further shipments of the Johnson & Johnson vaccine — projected to total tens of millions of doses in the next month — were...
    Some 15 million doses of Johnson & Johnson's one-shot coronavirus vaccine have been ruined after employees at a Baltimore manufacturing plant accidentally swapped two ingredients, the New York Times reported Wednesday.   The gaff occurred two weeks ago and will delay tens of millions doses slated to ship next month while the FDA investigates.  J&J blamed the mix-up on human error and says that 11 million doses that shipped this week were not affected.  White House officials told the Times that the J&J fiasco will not prevent the U.S. from reaching President Biden's goal of having enough COVID-19 vaccine doses in the national stockpile to inoculate every American adult by the end of May.  Some 15 million doses of Johnson & Johnson's one-shot coronavirus vaccine have been ruined after employees at a Baltimore manufacturing plant accidentally swapped two ingredients RELATED ARTICLES Previous 1 Next Fewer than 5% of COVID-19 infections are acquired in... Share this article Share Read more: Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up...
    MIDDLE RIVER, Md. (WJZ) — A fixture in eastern Baltimore County is closing its doors after decades in business. Lockheed Martin plans to close its manufacturing plant in Middle River within the next two years. READ MORE: U.S. Park Police Name Pamela Smith As New Chief, First Black Woman To Lead The Force The 465 plant employees will be relocated, or offered telework. READ MORE: Bobbleheads Memorialize Baltimore Sports Superfan Mo Gaba, Raise Money For Charity Currently, the plant produces vertical launch systems and other equipment for U.S. warships. MORE NEWS: Baltimore Mayor, Maryland Governor Clash After Hogan Says City Getting More Vaccines Than ‘Entitled To’ In Response To WJZ Question Get alerts from WJZ first! Follow WJZ on Facebook and download the app.
    BALTIMORE COUNTY, Md. (WJZ) — In an effort to reduce greenhouse gases and increase Baltimore County’s tree canopy, county executive Johnny Olszewski is calling on property owners to plant more trees. He says residents can request trees to be planted on their property for free, or they can do it themselves. Olszewski is also asking everyone to track the trees they plant. The goal is to have 5,000 new trees ready for Earth Day next year.
1